Search Results

Displaying Results 1-1 of 1 "'RVNC'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.

May 08, 2026, 10:00 ET Entwistle & Cappucci LLP and Saxena White P.A. Announce a Proposed Settlement in the Revance Therapeutics, Inc. Securities Litigation

FrensleyIF YOU PURCHASED OR ACQUIRED REVANCE SECURITIES, INCLUDING COMMON STOCK (CUSIP: 761330109; TICKER "RVNC") AND 1.75% FIXED COUPON CONVERTIBLE SENIOR UNSECURED NOTES (CUSIP: 761330AB5), DURING THE PERIOD OF FEBRUARY 29, 2024 THROUGH THE CLOSE OF THE MERGER

More news about: Entwistle & Cappucci LLP and Saxena White P.A.

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.